Drug comparisons
Pioglitazone vs Dulaglutide
Pioglitazone vs Dulaglutide for T2DM: oral TZD vs weekly GLP-1 injection. Compare mechanisms, weight effects, CV risks, black box warnings, and patient fit.
No comparison dimensions are available for this page.
Clinical context
Triggered when a T2DM patient on or considering a TZD needs intensification or switch due to weight gain, heart-failure risk, or desire for proven CV benefit from a GLP-1 agonist.
Bottom line
Dulaglutide generally offers more favorable weight and cardiovascular profiles, yet Pioglitazone remains a viable oral alternative when injections are declined and heart failure is absent.
All medication comparisons